GlobeNewswire Inc.··NaLeonaBio Expands Leadership, Readies ALS Data for June Conference Circuit
LeonaBio announces June 2026 conference participation for ALS candidate ATH-1105 and oncology panel, while appointing three new board directors.
LONAboard appointmentsclinical-stage biopharmaceutical